PIP Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5102952-Each-of-1 | In Stock | ₹ 46,502.50 |
PIPA5102952 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 46,502.50
GST (18%): ₹ 8,370.45
Total Price: ₹ 54,872.95
Antigen
PIP
Classification
Polyclonal
Conjugate
Unconjugated
Gene
PIP
Gene Alias
14 kDa submandibular gland protein; gcdfp 15; GCDFP15; GCDFP-15; gp17; GPIP4; Gross cystic disease fluid protein 15; HGNC:8993; mSMGP; PIP; prolactin induced protein; prolactin-induced protein; Prolactin-inducible protein; prolactin-inducible protein homolog; SABP; secretory actin-binding protein; SMGP
Host Species
Rabbit
Purification Method
Affinity chromatography
Regulatory Status
RUO
Gene ID (Entrez)
18716, 5304, 64673
Content And Storage
-20°C
Form
Liquid
Applications
Immunocytochemistry, Immunohistochemistry (Paraffin), Western Blot
Concentration
1 mg/mL
Formulation
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
Gene Accession No.
O70417, P02816, P12273
Gene Symbols
PIP
Immunogen
A synthesized peptide derived from human PIP(Accession P12273), corresponding to amino acid residues V18-V68.
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human, Mouse, Rat
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Antibody detects endogenous levels of total PIP
- Gross cystic disease of the breast is benign premenopausal disorder in which cysts are a predominant pathological lesion
- These cysts appear to be formed from excessive apocrine cystic secretions
- This fluid is composed of several glycoproteins including a unique 15kDa monomer protein, Gross Cystic Disease Fluid Protein-15 (GCDFP15)
- Cytosolic analysis of normal tissue specimens from all major organs has demonstrated GCDFP15 in apocrine epithelia, lacrimal, ceruminous and Moll's glands and in numerous serous cells of the submandibular, tracheal, bronchial, sublingual and minor salivary glands
- GCDFP15 and prostate specific antigen are co-expressed in androgen receptor-positive breast tumours.